Client Result
Carlyle and SK Capital to Acquire bluebird bio
1 minute read | March.07.2025

1 minute read | March.07.2025
2 minute read | April.10.2024
First Wave BioPharma, Inc., a clinical-stage biopharmaceutical company, has acquired ImmunogenX in an all-stock transaction.
2 minute read | April.10.2024
Onconova Therapeutics and Trawsfynydd Therapeutics have entered into a definitive merger agreement to combine to form Traws Pharma.
2 minute read | July.20.2023
1 minute read | January.09.2023
June.27.2022
The primary focus of the acquisition is on the lead medicine, Tazverik® (tazemetostat), a first-in-class, chemotherapy-free EZH2a inhibitor.